Loading...
XETRILM1
Market cap320mUSD
Dec 23, Last price  
12.08EUR
1D
2.72%
1Q
-25.52%
Jan 2017
54.87%
Name

Medios AG

Chart & Performance

D1W1MN
XETR:ILM1 chart
P/E
16.38
P/S
0.17
EPS
0.74
Div Yield, %
0.00%
Shrs. gr., 5y
11.06%
Rev. gr., 5y
40.34%
Revenues
1.78b
+10.80%
1,037,5731,375,01735,224000133,210,908253,636,644327,829,818516,804,827626,543,0001,357,408,0001,610,777,0001,784,703,000
Net income
19m
+2.62%
00000004,134,3314,326,8449,759,8545,525,0007,402,00018,329,00018,810,000
CFO
16m
-55.81%
-3,700-80,6000103,36113,300-99,638-1,582,000816,000-3,135,563-449,286-38,115,00061,520,00037,122,00016,406,000
Earnings
Mar 25, 2025

Profile

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
URL
https://medios.ag/
IPO date
Jan 01, 1999
Employees
514
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,784,703
10.80%
1,610,777
18.67%
1,357,408
116.65%
Cost of revenue
1,684,287
1,509,946
1,294,157
Unusual Expense (Income)
NOPBT
100,416
100,831
63,251
NOPBT Margin
5.63%
6.26%
4.66%
Operating Taxes
10,560
9,492
6,174
Tax Rate
10.52%
9.41%
9.76%
NOPAT
89,856
91,339
57,077
Net income
18,810
2.62%
18,329
147.62%
7,402
33.97%
Dividends
Dividend yield
Proceeds from repurchase of equity
(53)
73,308
BB yield
0.01%
-9.37%
Debt
Debt current
2,493
2,469
34,420
Long-term debt
31,795
32,714
32,658
Deferred revenue
Other long-term liabilities
3,849
4,517
1,040
Net debt
(36,752)
(44,795)
(102,043)
Cash flow
Cash from operating activities
16,406
37,122
61,520
CAPEX
(1,207)
(5,064)
(12,821)
Cash from investing activities
(16,567)
(86,541)
17,364
Cash from financing activities
(8,012)
(39,799)
69,759
FCF
53,788
62,324
65,336
Balance
Cash
71,040
79,213
168,431
Long term investments
765
690
Excess cash
101,251
Stockholders' equity
89,661
448,045
394,164
Invested Capital
489,804
450,728
321,530
ROIC
19.11%
23.66%
23.70%
ROCE
19.54%
21.14%
14.29%
EV
Common stock shares outstanding
23,806
23,868
20,161
Price
15.80
-9.92%
17.54
-54.79%
38.80
3.74%
Market cap
376,135
-10.15%
418,645
-46.48%
782,247
30.67%
EV
339,383
373,850
680,204
EBITDA
121,456
123,079
82,625
EV/EBITDA
2.79
3.04
8.23
Interest
2,407
1,257
1,727
Interest/NOPBT
2.40%
1.25%
2.73%